We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TORO:NASDAQToro Corp. Analysis

Data as of 2026-09-01 - not real-time

$6.12

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Toro Corp. is priced at $6.12 and its moving averages line up in bullish order, the shorter sitting above the longer. The last 30 days have gained 24.6%. With RSI at 66.3 the momentum picture is approaching overbought, alongside a bullish MACD signal. The recent range runs from support at $5.06 up to resistance at $6.49.
Multiples put this in fair territory: 306.0 times earnings against the sector's 21.6. Revenue is growing at 7.7% on a 22.7% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 31.0%, a beta of 1.74 and a maximum drawdown of 42.2%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Near-term and long-term part ways here — buy short-term against hold longer out, with 1/10 conviction on the long call.

Top Market Events

LIMASSOL, Cyprus, Sept. 16, 2025 GLOBE NEWSWIRE -- Toro Corp. NASDAQ: TORO “Toro”, or the “Company” , a global...ADVFN1monToro Corp. Announces the Date of its 2026 Annual General Meeting of ShareholdersToro Corp. NASDAQ: TORO...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 4.79
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 306.0 versus sector average of 21.6
  • Trading above the 200-day average of 4.79

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 306.0 versus sector average of 21.6
  • Profit margin of 22.7% is healthy
  • Negative free cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth7.70%
Profit Margin22.67%
P/E Ratio306.0
ROE1.45%
ROA-0.87%
P/B Ratio0.8
Op. Cash Flow$-7908704
Free Cash Flow$-49836168
Industry P/E21.6

Technical Analysis

TrendBullish
RSI66.3
Support$5.06
Resistance$6.49
MA 20$5.82
MA 50$5.33
MA 200$4.79
MACDBullish
VolumeStable
Fear & Greed Index93.16

Valuation

GradeFair
TypeBlend

Risk Assessment

Beta1.74
Volatility30.98%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.